Kuwait Human Papilloma Virus Testing Market Size & Outlook

The human papilloma virus testing market in Kuwait is expected to reach a projected revenue of US$ 17.6 million by 2033. A compound annual growth rate of 16.6% is expected of Kuwait human papilloma virus testing market from 2025 to 2033.
Revenue, 2024 (US$M)
$4.5
Forecast, 2033 (US$M)
$17.6
CAGR, 2025 - 2033
16.6%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait human papilloma virus testing market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Kuwait human papilloma virus testing market highlights

  • The Kuwait human papilloma virus testing market generated a revenue of USD 4.5 million in 2024 and is expected to reach USD 17.6 million by 2033.
  • The Kuwait market is expected to grow at a CAGR of 16.6% from 2025 to 2033.
  • In terms of segment, cervical cancer screening was the largest revenue generating application in 2024.
  • Cervical Cancer Screening is the most lucrative application segment registering the fastest growth during the forecast period.


Human papilloma virus testing market data book summary

Market revenue in 2024USD 4.5 million
Market revenue in 2033USD 17.6 million
Growth rate16.6% (CAGR from 2025 to 2033)
Largest segmentCervical cancer screening
Fastest growing segmentCervical Cancer Screening
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCervical Cancer Screening, Vaginal Cancer Screening
Key market players worldwideAbbott Laboratories, Biomedical Diagnostics, BioMerieux SA, CeMines, Bio-Rad Laboratories Inc, Epigenomics AG, Fujirebio Diagnostics, Guided Therapeutics Inc, Oncolab, Hologic Inc, Qiagen NV, Radiant Pharmaceuticals, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.3% of the global human papilloma virus testing market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, South Africa human papilloma virus testing market is projected to lead the regional market in terms of revenue in 2033.
  • Kuwait is the fastest growing regional market in Middle East & Africa and is projected to reach USD 17.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Human Papilloma Virus Testing Market Companies

Name Profile # Employees HQ Website
Radiant Pharmaceuticals View profile 1001-5000 Dhaka, Dhaka, Bangladesh, Asia http://www.radiantpharmabd.com
Oncolab View profile 1-10 Boston, Massachusetts, United States, North America http://oncolabinc.com/index.html
CeMines View profile 1-10 Evergreen, Colorado, United States, North America http://www.cemines.com
Biomedical Diagnostics View profile 1-10 Antwerp, Antwerpen, Belgium, Europe https://www.bmd.be/
Fujirebio Diagnostics View profile 5001-10000 Malvern, Pennsylvania, United States, North America http://www.fdi.com/
F. Hoffmann-La Roche Ltd. View profile - - -
Guided Therapeutics Inc View profile 4 5835 Peachtree Corners East, Suite B, Norcross, GA, United States, 30092 https://www.guidedinc.com
Epigenomics AG View profile 18 Geneststrasse 5, Berlin, BB, Germany, 10829 https://www.epigenomics.com
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Kuwait human papilloma virus testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human papilloma virus testing market will help companies and investors design strategic landscapes.


Cervical cancer screening was the largest segment with a revenue share of 88.89% in 2024. Horizon Databook has segmented the Kuwait human papilloma virus testing market based on cervical cancer screening, vaginal cancer screening covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Kuwait human papilloma virus testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait human papilloma virus testing market databook

  • Our clientele includes a mix of human papilloma virus testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait human papilloma virus testing market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait human papilloma virus testing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait human papilloma virus testing market size, by application, 2021-2033 (US$M)

Kuwait Human Papilloma Virus Testing Market Outlook Share, 2024 & 2033 (US$M)

Kuwait human papilloma virus testing market size, by application, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online